Biotech ‘Diamonds-in-the-Rough’ Promise Huge Potential Returns: Rahul Jasuja
Posted on July 19, 2012 at 17:00 PM EDT
The Life Sciences Report: Would you briefly touch on your themes? Rahul Jasuja: Let’s start with gout. Gout is a forgotten disease, but over the last couple of decades, owing to the Western diet . . . → Read More: Biotech ‘Diamonds-in-the-Rough’ Promise Huge Potential Returns: Rahul Jasuja

The Life Sciences Report: Would you briefly touch on your themes?

Rahul Jasuja: Let’s start with gout. Gout is a forgotten disease, but over the last couple of decades, owing to the Western diet and lifestyle, it has come back with a vengeance. It is also different than the old gout, which was known as a disease of kings, queens and the wealthy—the privileged who could afford to consume heavier diets rich in protein and alcohol. The culprit in gout is serum uric acid. When uric acid levels in blood are elevated, uric acid crystals form and trigger an inflammatory cascade that causes painful … [visit site to read more]

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here